Publications by authors named "Alessandra Ferrajoli"

100Publications

Metastatic lung adenocarcinoma mimicking Richter transformation in a patient with chronic lymphocytic leukemia.

Leuk Res 2020 Nov 13;98:106445. Epub 2020 Sep 13.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2020.106445DOI Listing
November 2020

Chronic Lymphocytic Leukemia.

Cancers (Basel) 2020 Sep 3;12(9). Epub 2020 Sep 3.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12092504DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564793PMC
September 2020

The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia.

Expert Rev Hematol 2020 Aug 26;13(8):885-894. Epub 2020 Jul 26.

Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2020.1796620DOI Listing
August 2020

Leukemic phase of Richter transformation: A mimic of acute myeloid leukemia that responded to Ibrutinib monotherapy.

Am J Hematol 2020 Mar 12. Epub 2020 Mar 12.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25782DOI Listing
March 2020

First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL).

Leuk Lymphoma 2020 02 30;61(2):445-449. Epub 2019 Sep 30.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1660967DOI Listing
February 2020

The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype.

Br J Haematol 2019 10 25;187(1):e1-e4. Epub 2019 Jul 25.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16117DOI Listing
October 2019

Ibrutinib and Venetoclax for First-Line Treatment of CLL.

N Engl J Med 2019 05;380(22):2095-2103

From the Departments of Leukemia (N.J., M. Keating, P.T., A.F., J.B., G.B., K.T., Z.E., T.K., M. Konopleva, Y.A., M.Y., C.D., P.B., M.O., N.P., E.J., K. Sasaki, K. Sondermann, N.C., C.W., A.A., H.K., W.W.), Lymphoma and Myeloma (N.F.), Hematopathology (R.K.-S., K.P., J.J.), Diagnostic Radiology (N.G.), Biostatistics (X.W.), and Experimental Therapeutics (W.P., V.G.), University of Texas M.D. Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1900574DOI Listing
May 2019

Treating Older Patients with Chronic Lymphocytic Leukemia: A Personalized Approach.

Drugs Aging 2019 09;36(9):841-851

Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40266-019-00678-5
Publisher Site
http://dx.doi.org/10.1007/s40266-019-00678-5DOI Listing
September 2019

Co-occurrence of chronic myeloid leukemia with chronic lymphocytic leukemia: a report of two cases.

Leuk Lymphoma 2019 06 11;60(6):1568-1571. Epub 2019 Jan 11.

a Department of Leukemia , UT MD Anderson Cancer center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1547902DOI Listing
June 2019

Lenalidomide can be safely combined with chlorambucil and rituximab in older patients with chronic lymphocytic leukemia.

Haematologica 2019 01;104(1):9-12

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.206359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312007PMC
January 2019

A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia.

Br J Haematol 2019 05 8;185(3):606-608. Epub 2018 Nov 8.

Department of Leukemia, the University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15581DOI Listing
May 2019

Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.

N Engl J Med 2018 10;379(15):1443-1451

From the Departments of Stem Cell Transplantation and Cellular Therapy (M.M., A.O., D.M., S.A., I.K., L.L., R.C., E.J.S., K.R.), Infectious Diseases (V.M.), Neuro-Oncology (S.T.), Diagnostic Radiology (T.L.C.), and Leukemia (A.F.), M.D. Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1801540
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1801540DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283403PMC
October 2018

STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells.

Oncotarget 2018 Sep 14;9(72):33710-33718. Epub 2018 Sep 14.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154750PMC
September 2018

Approaches to Chronic Lymphocytic Leukemia Therapy in the Era of New Agents: The Conundrum of Many Options.

Am Soc Clin Oncol Educ Book 2018 May;38:580-591

From the Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; Cardinal Health Specialty Solutions, Chicago, IL; Chronic Lymphocytic Leukemia Program, Memorial Sloan Kettering Cancer Center, New York, NY; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_200691DOI Listing
May 2018

Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia.

Leuk Lymphoma 2019 02 18;60(2):535-537. Epub 2018 Jun 18.

a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1474527DOI Listing
February 2019

STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells.

Oncotarget 2018 Apr 20;9(30):21268-21280. Epub 2018 Apr 20.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940394PMC
April 2018

L-carnitine and Vitamin B Complex for the Treatment of Pegasparaginase-induced Hyperbilirubinemia.

Clin Lymphoma Myeloma Leuk 2018 05 26;18(5):e191-e195. Epub 2018 Feb 26.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.02.014DOI Listing
May 2018

Prognostic Factors in the Era of Targeted Therapies in CLL.

Curr Hematol Malig Rep 2018 04;13(2):78-90

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-018-0439-9DOI Listing
April 2018

Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.

Leuk Lymphoma 2018 11 21;59(11):2686-2691. Epub 2018 Feb 21.

a Department of Leukemia , University of Texas MD Anderson Cancer Center , Houston , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1439167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135679PMC
November 2018

Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study.

J Clin Oncol 2018 Apr 15;36(10):959-967. Epub 2018 Feb 15.

Jessica P. Hwang, Scott B. Cantor, Andrea Barbo, Heather Y. Lin, Jessica T. Foreman, Harrys A. Torres, Bruno P. Granwehr, Ethan Miller, Cathy Eng, George R. Simon, Sairah Ahmed, Alessandra Ferrajoli, Jorge Romaguera, and Maria E. Suarez-Almazor, The University of Texas MD Anderson Cancer Center; John M. Vierling, Baylor College of Medicine, Houston, TX; Anna S. Lok, University of Michigan, Ann Arbor, MI; and Michael J. Fisch, Aim Specialty Health, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.6387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351320PMC
April 2018

Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant.

Biol Blood Marrow Transplant 2018 05 9;24(5):1094-1098. Epub 2018 Feb 9.

Houston VA Health Sciences Research and Development, Michael E. DeBakey VA Medical Center, Houston, Texas; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.01.019DOI Listing
May 2018

Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report.

Hematol Oncol Stem Cell Ther 2019 Sep 16;12(3):161-165. Epub 2017 Aug 16.

Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S16583876173009
Publisher Site
http://dx.doi.org/10.1016/j.hemonc.2017.07.004DOI Listing
September 2019

Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections.

EBioMedicine 2017 Jun 19;20:182-192. Epub 2017 Apr 19.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The RNA Interference and Non-Coding RNA Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2017.04.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478184PMC
June 2017

Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia.

Onco Targets Ther 2017 29;10:1909-1914. Epub 2017 Mar 29.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S98689DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384733PMC
March 2017

microRNA Therapeutics in Cancer - An Emerging Concept.

EBioMedicine 2016 Oct 20;12:34-42. Epub 2016 Sep 20.

Departments of Experimental Therapeutics and Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA and Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2016.09.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078622PMC
October 2016

Membranoproliferative glomerulonephritis and acute renal failure in a patient with chronic lymphocytic leukemia: Response to obinutuzumab.

Hematol Oncol Stem Cell Ther 2017 Sep 23;10(3):151-154. Epub 2016 Jun 23.

Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hemonc.2016.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001725PMC
September 2017